THE IMPACT OF RITUXIMAB AND RADIOTHERAPY ON OUTCOME OF PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMA AND SKELETAL INVOLVEMENT

098

  • Held, G.
  • Zeynalova, S.
  • Murawski, N.
  • Ziepert, M.
  • Kempf, B.
  • Viardot, A.
  • Dreyling, M.
  • Hallek, M.
  • Witzens-Harig, M.
  • Fleckenstein, J.
  • Ruebe, C.
  • Zwick, C.
  • Glass, B.
  • Schmitz, N.
  • Pfreundschuh, M.

  • 1Internal Medicine I, Saarland University Medical School, Homburg, Germany

    2IMISE, University Leipzig, Leipzig, Germany

    3Hematology/Oncology, Klinikum Landshut, Landshut, Germany

    4Internal Medicine III, University of Ulm, Ulm, Germany

    5Internal Medicine I, Klinikum Gro, Muenchen, Germany

    6Hematology/Oncology, University Hospital Cologne, Cologne, Germany

    7Hematology/Oncology, University Hospital of Heidelberg, Heidelberg, Germany

    8Radiooncology, Saarland University Medical School, Homburg, Germany

    9Hematology/Oncology, Asklepios Hospital St. Georg, Hamburg, Germany

Hematological Oncology 31:p 128-129, June 2013.
Copyright © 2013 John Wiley & Sons, Inc.